What is eBlu Solutions?
eBlu Solutions operates a secure software platform designed to address the complexities of electronic prior authorization and benefits verification within the infusion-based specialty medication sector. The company's technology aims to simplify and streamline the often fragmented approval process for critical specialty drug treatments. eBlu Solutions currently serves a diverse range of medical specialties, including rheumatology, neurology, gastroenterology, and allergy & asthma, positioning itself as a key enabler of efficient healthcare delivery.
How much funding has eBlu Solutions raised?
eBlu Solutions has raised a total of $11.6M across 2 funding rounds:
Debt
$150K
Series A
$11.4M
Debt (2020): $150K with participation from PPP
Series A (2021): $11.4M led by Mutual Capital Partners LLC, OCA Ventures, and FCA Venture Partners
Key Investors in eBlu Solutions
OCA Ventures
OCA Ventures is dedicated to assisting entrepreneurs in the development of successful companies, providing support and resources to help startups thrive. Their focus is on fostering innovation and growth among emerging businesses.
FCA Venture Partners
FCA Venture Partners, formerly Clayton Associates, invests in start-up and early-stage companies, evolving from an incubator model to managing dedicated venture funds. They support entrepreneurs through mentorship and capital, focusing on market needs.
PPP
Public-Private Partnership
What's next for eBlu Solutions?
The recent major strategic investment signals a new phase of growth and development for eBlu Solutions. This capital infusion is expected to fuel further platform enhancements, expand market reach, and potentially explore new specialty areas or technological integrations. The company's focus on streamlining prior authorization processes aligns with broader healthcare industry trends towards digital transformation and improved patient access to necessary treatments, suggesting a strong trajectory for future expansion and market leadership.
See full eBlu Solutions company page
